Office of Technology Development

Share
Share

The Office of Technology Development

Our 2022 work to date
  • 121 Invention Disclosures
  • 139 Patent Applications
  • 40 Patents Issued

The Office of Technology Development manages Memorial Sloan Kettering’s world-class portfolio of intellectual property. We are responsible for:

  • Identifying and evaluating new inventions
  • Seeking patent protection
  • Developing, managing, and commercializing the institution’s innovations
  • Facilitating start-up creation.

The goal of our technology transfer activities is to ensure that scientific research at Memorial Sloan Kettering is developed and applied for the common good.

For legal support relating to intellectual property  and pre-clinical or clinical research agreements, contact a member of our Legal team.

  • About Us
    The Office of Technology Development’s mission is to ensure that Memorial Sloan Kettering’s inventions have the greatest chance of benefiting patients.
  • Our Staff
    The office is staffed by technology transfer professionals with backgrounds in science, intellectual property, and business development.
  • Success Stories
    Research conducted at Memorial Sloan Kettering has produced ten drugs FDA approved for marketing, and one product approved by the USDA.
  • Technologies Available for Licensing
    We offer opportunities for developing new devices, diagnostics, research tools, therapeutics, and vaccines.
  • Digital Health Projects
    At MSK, we are leaders in the field of digital health. Our investigators, clinicians, and health technology professionals are working on a wide range of opportunities to bring the promise of our cutting-edge technologies, deep expertise in clinical validation, and portfolio of digital assets to our mission of improving the health care and quality of life of people with cancer.
  • MSK Innovation Hub
    As the world’s oldest and largest private cancer center, MSK has devoted more than 135 years to exceptional patient care, influential educational programs, and innovative research to discover more effective strategies to prevent, control and, ultimately, cure cancer. The institution is home to an exceptional community of researchers, clinicians, and digital health professionals and it is committed to advancing the care and treatment of cancer through digital health and life sciences innovation.  
  • Tangible Materials Available for Licensing
    We have an extensive collection of tangible research materials, including cell lines, antibodies, reagents, and mouse models, which are available for licensing on a non-exclusive basis for research and commercial purposes.
  • Contact OTD
    Learn more about how to reach us by phone, e-mail, regular mail, or courier.
For MSK Investigators

View the Office of Technology Development’s Intranet page.